ODT’s Top 10 Articles from December

Most-read news items from December included first surgical uses for devices, leadership changes, FDA approvals, and more. 

The Treace SpeedPlate MircoQuad implant was used in its first successful procedures. The implant expands on the SpeedPlate’s broad utility and features multiple fixation points on each side of the joint to deliver dynamic compression, with rotational stability through a once-inch incision.

The NextAR surgical application from Medacta was used in its first anatomic shoulder replacement procedure in the US. NextAR was used in combination with the Medacta Shoulder System and leverages augmented reality to assist trained surgeons in accurately placing shoulder prostheses while respecting each patient’s anatomy.

Former Stryker VP, Lane Major was appointed CEO of Zavation. Major has over 20 years of experience and succeeds Zavation founder Jeffery Johnson, who will continue to support the company as executive chairman of the board.

Paragon 28 increased the size of its board of directors by adding Dave Demski as an independent director for the company. Demski was most recently president and CEO of Globus Medical from August 2017 to April 2022. 

Smith+Nephew expanded its AETOS Shoulder System with newly FDA 510(k) cleared AETOS Stemless. Zimmer Biomet also gained FDA clearance for its Persona SoluTion porous plasma spray (PPS) femur.

1. Bone Health Technologies to Begin Shipping Osteoboost for Low Bone Density
2. Zimmer Biomet Gets FDA OK for Persona SoluTion PPS Femur
3. Zavation Names Former Stryker VP Lane Major as CEO
4. Revolutionizing Meniscus Repair: A New Standard of Care 
5. Treace Has 1st Procedures Using SpeedPlate MicroQuad Implant
6. Paragon 28 Welcomes Ex-Globus CEO Dave Demski to Its Board
7. Medacta Announces 1st NextAR Augmented Reality Surgical Application in the US
8. M&A, Strategic Partnerships Shaped the Orthopedic Industry in 2024
9. Smith+Nephew Expands AETOS Shoulder System
10. Trends in the US Orthopedic Trauma Device Market